Your Vault RIM Was Optimized at Go-Live. Is It Optimized Today?

Your Vault RIM Was Optimized at Go-Live. Is It Optimized Today?

When organizations implement Veeva Vault RIM, tremendous effort goes into designing the right solution. Business processes are mapped, security is carefully configured, workflows are established, integrations are built, and governance models are defined. Months of planning culminate in a platform designed to support the organization’s regulatory operations for years to come.

But no organization stands still.

Regulations evolve. The business grows through acquisitions. New products enter development. Organizational structures change. Administrators respond to new requests, implement enhancements, adjust security, and introduce new processes to meet immediate business needs. Meanwhile, Veeva continues to release new capabilities three times each year, providing opportunities to improve efficiency, simplify administration, and enhance regulatory operations.

Each of these decisions is reasonable on its own. Collectively, however, they can gradually move the platform away from the environment that was originally designed.

The Hidden Cost of Platform Drift

Enterprise software doesn’t usually fail because of one poor decision. Instead, it evolves through hundreds of small decisions made over many years.

    • A configurable feature isn’t enabled because it isn’t immediately needed.
    • A custom workflow is built to address a business requirement that existed at the time.
    • Security permissions become increasingly granular as new teams and responsibilities are added.
    • Manual processes remain in place because “that’s how we’ve always done it.”

Each decision solves a legitimate problem. The challenge is that very few organizations periodically step back to ask whether those decisions still make sense today.

The result is what we call platform drift: the gradual accumulation of configuration changes, administrative decisions, and business adaptations that slowly move the platform away from its most efficient and maintainable state.

Yesterday’s Decisions May Limit Tomorrow’s Capabilities

One of the greatest strengths of Veeva Vault RIM is its continuous innovation. Every year, Veeva delivers new functionality designed to improve regulatory operations, automate manual activities, and help organizations respond to changing regulatory requirements. Many of these capabilities build upon configuration options or foundational features that may have been available for years.

Organizations often discover that decisions made during the original implementation now influence their ability to adopt those newer capabilities.

    • A configurable feature was left disabled because there was no immediate business value at the time.
    • A highly customized workflow solved an earlier challenge but now duplicates standard product functionality.
    • An increasingly complex security model makes routine administration more difficult than necessary.

None of these situations indicates a poor implementation. They simply reflect the reality that both the business and the software have evolved. Without periodically reassessing the platform, organizations can unknowingly miss opportunities to simplify operations, improve user adoption, and gain more value from capabilities they already own.

More Features Don’t Always Mean More Value

Many organizations assume they’re getting maximum value simply because they’re running the latest version of Vault RIM. Version currency, however, is only part of the equation.

Real platform maturity depends on questions such as:

    • Are we taking advantage of the capabilities available to us?
    • Have our business processes become unnecessarily complex over time?
    • Is our security model enabling collaboration or creating administrative overhead?
    • Is our regulatory data organized consistently and supporting efficient operations?
    • Are users relying on manual workarounds that newer functionality could eliminate?
    • Does our documentation still reflect how the system actually operates?

These are business questions, not simply technical ones. Answering them requires an objective assessment of how the platform supports today’s organization rather than the organization that existed at go-live.

A Health Check Should Look Beyond Technology

An effective platform assessment should evaluate more than configuration settings. It should examine how people, processes, governance, and technology work together to support regulatory operations.

HealthCheckAssist was developed specifically for that purpose.

Through stakeholder interviews, feature utilization reviews, data and document organization assessments, security evaluations, and training and documentation reviews, HealthCheckAssist provides organizations with an objective understanding of how effectively their Vault RIM environment supports current business needs.

Rather than producing a list of technical observations, the assessment identifies opportunities to improve solution utilization, reduce administrative complexity, strengthen governance, improve data quality, and develop a practical roadmap for future optimization.

Making the Most of Your Investment

Implementing Vault RIM represents a significant investment of time, resources, and organizational effort.

The objective shouldn’t simply be to keep the system running. It should be to ensure the platform continues to evolve alongside the business, enabling users to take advantage of new capabilities, reducing unnecessary complexity, and supporting efficient regulatory operations for years to come.

The best-performing organizations recognize that optimization is not a one-time implementation activity. It is an ongoing process of evaluating whether yesterday’s decisions still support today’s business objectives.

If it has been several years since your Vault RIM environment was assessed, now may be the right time to ask a simple question: Is your platform still optimized? Or has it gradually drifted away from its full potential?

Learn how HealthCheckAssist can help your organization evaluate its Vault RIM environment, identify optimization opportunities, and maximize the value of your investment by downloading the datasheet below.

Why RIM Modernization Projects Succeed or Fail BEFORE Vendor Selection

Why RIM Modernization Projects Succeed or Fail BEFORE Vendor Selection

Selecting a new Regulatory Information Management (RIM) platform is one of the most significant technology decisions a Life Sciences organization will make. The chosen platform will influence regulatory operations, compliance, data governance, and business agility for years to come.

As organizations expand product portfolios, enter new markets, and adapt to evolving regulatory requirements, many begin asking the same question: Does our current RIM environment still support our business, or is it time to modernize?

Organizations quickly discover that selecting a platform is only one part of a much larger challenge..

The Greatest Risks Are Organizational, Not Technical

Most regulatory organizations recognize the challenges limiting operational efficiencies. Regulatory data is spread across multiple systems, reporting requires significant manual effort, and teams follow different processes across regions or business units. The result is inconsistent information, limited visibility, and reduced confidence in regulatory operations.

While these issues often appear to be technology limitations, they are typically the result of years of organizational evolution. As companies expand into new markets, acquire products, adapt to changing regulations, and grow their teams, processes naturally evolve. Local workarounds emerge, governance practices drift, and information is managed differently across functions and regions. Over time, this complexity becomes embedded within the technology landscape itself.

These inconsistencies often remain hidden until requirements gathering or implementation activities begin. At that point, differences between teams, regions, and business units become impossible to ignore. New software alone cannot resolve these underlying challenges. Because regulatory information supports product planning, market expansion, compliance, and strategic decision-making, inconsistent processes and unreliable data quickly become business risks.  

The objective is not simply to replace technology; it is to modernize how people, processes, information, and technology work together. Achieving this requires a different approach.

Change Your Focus: Goals, Not Feature Lists

Successful modernization begins by asking a different question. Instead of asking which platform has the best capabilities, organizations should ask what they are trying to achieve. Without clearly defined future-state objectives, teams become focused on vendor demonstrations, feature comparisons, and technical evaluations rather than business outcomes they need to deliver.

The most successful organizations first understand their current state, identify operational inefficiencies, define future capabilities, and engage stakeholders across Regulatory Affairs, Regulatory Operations, IT, and business leadership. This confirms modernization goals reflect enterprise priorities rather than the needs of a single function.

With this foundation in place, technology is evaluated against business objectives, not feature checklists, resulting in solutions that support long-term regulatory strategy rather than simply replacing existing systems.

SelectAssist℠: Proven Structure for a Complex Decision

Few organizations undertake RIM modernization frequently enough to develop a repeatable approach. Regulatory leaders may oversee one or two major platform transformations during their careers, yet the decisions they make influence operations for years.

SelectAssist was developed by fme to help Life Sciences organizations navigate these decisions through a structured, vendor-neutral methodology. Through executive interviews, stakeholder workshops, process and governance assessments, current-state analysis, and business case development, we establish a clear understanding of your organization’s operating model, future-state objectives, and critical business requirements.

Using this foundation, we objectively evaluate and score RIM platforms against your defined criteria, providing leadership with a clear understanding of each solution’s strengths, tradeoffs, risks, and long-term fit. Rather than selecting technology based on demonstrations or feature lists, organizations make informed decisions aligned with their regulatory strategy, operating model, and future growth.

Because successful modernization depends on more than technology, SelectAssist also evaluates the people, processes, governance, data, and organizational readiness required to support a successful transformation.

If your organization is evaluating a new RIM platform, or simply wants confidence that it is asking the right questions before engaging software vendors, we’d welcome the opportunity to discuss your modernization goals. Download the SelectAssist datasheet to learn how our proven methodology helps Life Sciences organizations make informed, objective platform decisions with confidence.


About the Author

Meghan Carr, PMP

Meghan Carr, PMP, is Vice President of Commercial Operations at fme Life Sciences, leading global commercial strategy for regulated content and data modernization initiatives across the pharmaceutical and biotechnology industries. With more than 20 years of experience spanning Regulatory, Clinical, and Quality, she has worked with many of the world’s leading life sciences organizations on complex digital transformation programs.

Throughout her career with leading global software vendors, implementation partners, and technology service providers, Meghan has supported hundreds of technology evaluations, proposals, and transformation initiatives. This experience has provided a unique perspective on the platform selection process and the organizational factors that ultimately determine modernization success.

Analyze, Identify, and Improve Metadata in Minutes, Not Months

Analyze, Identify, and Improve Metadata in Minutes, Not Months

Regulated industries generate enormous volumes of documentation every year. Regulatory submissions, clinical reports, quality documentation, and scientific studies all contribute to a quickly expanding library of critical information. An essential part of that information is the document metadata, the structure that allows documents to be categorized, understood, and retrieved in context.

Unfortunately, as a company grows and matures, data silos get moved, updated, and combined, causing metadata to be disconnected from the documents and directories. Staff and process changes, archiving initiatives, garbled translations, or system improvements can all erode the quality, accuracy, and reliability of critical information.

What started as a well-organized repository slowly becomes something much harder to trust.

The Problem You Don’t See Until It’s A Big Problem

The depth of the disconnects are often not fully realized until the organization decides to consolidate or migrate their repositories to a modern technology solution. What was assumed to be ‘migration ready data’ is discovered to be:

    • Incomplete and inconsistent due to years evolving standards and interpretations
    • Structured in ways that are incompatible with modern platforms
    • Missing information that is required by new regulatory requirements
    • Complicated by legacy content from mergers, acquisitions, or past migrations

Finding and fixing these issues manually requires reviewing thousands, or even millions of documents. It demands skilled internal resources, consumes valuable time, and often puts critical projects at risk.

For teams already operating under tight timelines, this effort can increase costs, delay migrations, and divert focus from higher-value work.

A New Approach to Metadata Recovery

Recent advances in artificial intelligence (AI) and natural language processing (NLP) are transforming how organizations approach metadata remediation. Rather than relying on manual review, AI-powered tools promise to analyze documents at scale, identify patterns, and extract metadata directly from the content itself. This process transforms unstructured documents into searchable and structured information assets recovering valuable information that was previously hidden inside document libraries.

But there’s a catch.
The majority of AI and NLP models were built and trained on generic datasets, not on highly-specialized, regulated content. Without domain expertise, they can do part of the job, but there’s no way to be sure the information is accurate, consistent, and compliant. This often leads to additional validation effort, delays, and uncertainty, undermining the very efficiency gains AI promises to deliver.

There’s a better way.

Proven AI and NLP-Powered Analysis with fme’s MetadataAssist

For over 25 years fme has been helping the largest firms in regulated industries migrate their repositories of complex regulated data and documents into, out of, and between the most powerful content management platforms from OpenText, Hyland, Veeva, Microsoft, and more.

With this experience and knowledge, we developed MetadataAssist™, a solution specifically built to address the challenges of highly regulated environments. Built on insights gained from thousands of hours of fme migration projects, we trained our advanced artificial intelligence (AI) and natural language processing (NLP) tools to analyze and classify large volumes of highly regulated content ensuring complete accuracy, consistency, and regulatory compliance.  

fme MetadataAssist simplifies and accelerates the analysis, identification, categorization, and updating of metadata across millions of documents, completing in minutes what traditionally takes teams weeks or months.

MetadataAssist automatically examines:

    • Document metadata
    • File content
    • Folder and location structures
    • Context within documents

In a pharmaceutical environment, the solution can analyze documents across multiple formats and languages, identifying and extracting critical metadata such as:

    • Product name
    • Dosage strength
    • Dosage form
    • Regulatory identifiers
    • Scientific and contextual data

This is far beyond the basic extraction process of other generic solutions. MetadataAssist’s NLP technology interprets the context surrounding the metadata, allowing the system to understand how documents should be classified based on their content, purpose, and relevance. This industry-trained contextual understanding ensures more accurate classification and improved document usability across enterprise systems.

The result is a well-organized, accessible document library where content can be properly classified, easily searched, and efficiently managed within your CMS or migrated into a new repository or platform.

See fme’s MetadataAssist in Action

Whether you are streamlining your current environment or planning a larger platform consolidation or migration initiative, MetadataAssist can transform complex, disconnected content into structured, searchable, and regulatory compliant information.

To learn how fme MetadataAssist can transform your document repositories, download the datasheet below, and then contact us to schedule a demo and experience the power and flexibility of industry-trained and AI-driven metadata classification.

Join fme at the Pharmaceutical Manufacturing World Summit

Join fme at the Pharmaceutical Manufacturing World Summit

Every year, the Pharmaceutical Manufacturing World Summit in Boston brings together industry leaders, innovators, and manufacturing experts to explore the future of pharmaceutical production. As both attendees and sponsors, the fme team enjoys this unique opportunity to engage in meaningful conversations, exchange insights, and advise on the technology and data management strategies that shape Life Sciences manufacturing today. Many of the key themes that defined last year’s agenda continue to be critical topics within the industry.

Key Themes Shaping Pharmaceutical Manufacturing World Summit

Year after year, one common thread unifies the agenda: Data is the foundation of transformation for business success.

Whether enabling AI, supporting regulatory compliance, or driving operational efficiency, success depends on having trusted, structured, and accessible data across the product lifecycle. Here are some of the recent areas of focus we’ve repeatedly shared with our clients:

ECM Platform ServicesData as a Strategic Asset

One of the most important points of the conference is data is no longer just operational, it’s transformational. Organizations are increasingly relying on high-quality, accessible data to drive decision-making across supply chains, manufacturing performance, and patient safety.

The ability to treat data as a strategic asset rather than a byproduct has finally been recognized as a competitive differentiator, and has been fme’s focus and mission for over 25 years. We help companies maximize the value and power of their data, ensuring it is structured, reusable, and ready to migrate into powerful solutions that unlock its full value across the enterprise.

digital_infrastructure

Navigating Geopolitical Uncertainty

Global manufacturing strategies are being reshaped by shifting regulatory landscapes, trade policies, and geopolitical tensions. From increased pressure to localize production in the U.S. to evolving FDA leadership and AI regulation, companies are operating in an environment of heightened uncertainty and risk.

fme helps guide organizations through the dynamic data management challenges that can affect supply chain resilience, inspection readiness, and compliance strategies.

Infrastructure Investment and Digital Transformation

The scale of investment in modern manufacturing infrastructure is staggering. Leading pharmaceutical companies are building digitally native, highly automated facilities designed for flexibility, speed, and advanced modalities like cell and gene therapies.

Technologies such as digital twins, robotics, IIoT, and integrated MES/QMS platforms are becoming foundational. At the same time, organizations are recognizing that less than 1% of process data is often fully utilized, highlighting a major opportunity for transformation.

To ensure technology investments address both immediate and long-term needs, it is critical to work with a technology partner that understands the technical and business goals of an integrated research, development, and manufacturing pipeline.

Pricing Pressures Driving Efficiency

With rising costs across the industry, manufacturers are under pressure to do more with less. The focus has shifted toward reducing inefficiencies, eliminating rework, and accelerating system consolidation.

This is where digital enablement and automation powered by clean, high-integrity data are playing a critical role in turning compliance into a value-generating function rather than a cost center.

Innovation Accelerating at Scale

From AI-driven quality transformation to novel manufacturing platforms, innovation is rapidly reshaping the industry.

Highlights from last year included:

  • AI-enabled quality systems and predictive manufacturing
  • Expansion into advanced modalities like ADCs and cell therapies
  • End-to-end digital supply chain orchestration
  • Increasing use of GenAI to enhance quality and operational efficiency

Organizations are not just experimenting. They are scaling these innovations to drive measurable business outcomes before their competition.

Join Us at This Year’s Summit

We’re excited to return to the Pharmaceutical Manufacturing World Summit this year as a sponsor and continue the conversation with industry leaders.

If you’ll be attending, we’d love to connect! Contact us and we’ll schedule a time to discuss your current challenges, share our proven strategies and insights, or explore how to accelerate your digital and data initiatives. If you can’t attend and would like a summary of the essential topics and sessions, let us know.

DIA RSIDM 2026 Hot Topic: Data Quality Transformation

DIA RSIDM 2026 Hot Topic: Data Quality Transformation

An annual staple of the regulatory industry, DIA’s RSIDM brings together industry and regulatory stakeholders to discuss evolving data standards, requirements and effective data management strategies. This year, fme’s regulatory experts David Gwyn, Frank D’Entrone and Scott Coles will be attending and answering questions in Booth #116. Stop by and see us! We’d love to discuss your challenges and plans for 2026, and share our proven solutions for managing complex regulatory submissions.

The Real Story: Data Quality Transformation

As data migration experts for the Life Sciences industry, we’ve helped the world’s largest organizations move complex regulatory ecosystems into platforms and solutions that align with their business processes and goals. Through our experiences, we’ve also realized that the actual migration is only one chapter of a much larger story.

In fact, the most urgent and impactful challenges our clients face aren’t about switching platforms. They’re about the quality, readiness, governance, and trustworthiness of the data they already have. And according to our clients, that’s where fme shines far brighter than other providers and especially the newest ‘intelligent’ solutions.

We Are Data Quality Transformation Specialists

fme understands the organization and structure of a client’s data is a reflection of the meaning, use and purpose of the information embedded within. Data, metadata and content all add essential context to data, and each detail needs to be available to realize its full value.

This is why clients come to us; they recognize fme’s experts can evaluate and enrich their data before incorporating it into their technology platform and business processes. Whether it’s organizing legacy content, remediating years of inconsistent metadata, strengthening governance practices, or establishing stewardship models that scale across global regulatory teams, fme knows where to look, and how to ensure every element is structured for efficient and contextual use.

This is the work we’re doing right now—multi-million-dollar data readiness and remediation initiatives—with some of the world’s largest and most complex Life Sciences companies. These aren’t migration projects. They’re data projects that emphasize critical concepts:

  • Data readiness is the foundation for modernization and digital transformation.
  • Governance and stewardship drive regulatory confidence.
  • Quality transformation unlocks efficiency, compliance, and innovation.

And they reflect a reality that’s becoming impossible to ignore:
You don’t have to move to a new platform to improve. You just need better data.

Understand Where You Are First

This has been one of the biggest expansions in the strategies we use to serve our clients. A transformation doesn’t start with technology change. It starts with understanding your current state, and building the pathway to allow your data to power your business goals.

fme’s solutions like MetadataAssist℠ and HealthCheckAssist℠ are strategically designed to provide regulatory and RIM teams with a fast, structured way to evaluate:

  • What data exists
  • How clean or accurate it is
  • How well metadata models are applied
  • Where governance gaps are limiting efficiency
  • What improvements can be made without moving platforms

In many cases, clients discover that a migration is unnecessary, or at least not urgent. By improving their data quality and governance practices, they can dramatically increase the value of the systems they already use.

To Migrate or Not: Choosing What’s Next

Of course, some organizations ultimately decide that their current platform can’t support where they want their business to go. When that happens, we help them choose their next solution with clear quantitative and qualitative data to cut through the marketing jargon and seller-lingo that can obfuscate true capabilities and benefits.

SelectAssist℠ is a unique offering that pairs our regulatory experts with client stakeholders to guide them through detailed platform evaluations and selection based on:

  • Regulatory workflows
  • Data and metadata requirements
  • Change readiness
  • Long-term scalability
  • Integration and interoperability needs

It’s important to clarify that while fme has many platform partners, our goal is to guide clients to the best solution for their unique goals. We provide a holistic, data-justified perspective focused on their needs, not a quarterly sales quota.

When Migration Is the Answer, We Deliver with Precision

When the data is optimized, technology is selected, and the organization is ready to move platforms, fme’s 30 years of migration experience come into play. We have unmatched knowledge, proven methodologies and acceleration toolsets to execute seamless regulatory content and data migrations at scale most service providers have never touched.

We combine:

  • AI-driven automation
  • Proven methodologies
  • Industry-leading tools
  • Deep regulatory and compliance expertise

After hundreds of successful migration projects, we have the skill and knowledge to deliver a seamless, accurate, and validated transition first time, every time.

Learn More about Data Quality Transformation

fme is evolving along with our clients’ needs. The industry is hungry for organizations that understand not just platforms, but the data that fuels regulatory compliance, submission quality, operational efficiency, and innovation.

So when we say we’re data quality transformation specialists, we mean:

  • We assess.
  • We remediate.
  • We govern.
  • We steward.
  • We prepare for the future.
  • And yes, when it’s the right time, we migrate.

But the story always starts with data quality. Do you REALLY know yours?

If you want to understand the value your data could be delivering, or if you’re struggling to achieve efficiency and compliance with the information you already have, we’re here to help you make it happen. Download the resource below to learn more.

Webinar 🖥️ Merger-Ready RIM with TransferAssist℠

Webinar 🖥️ Merger-Ready RIM with TransferAssist℠

Today’s multi-million and billion dollar Life Sciences mergers and acquisitions rarely come with breathing room after the ink dries. From the moment a deal closes, IT and business leaders are expected to migrate and integrate data and systems without interrupting compliance, and often with limited forewarning or visibility into what they’ve acquired.

The risks of getting it wrong are real: missed deadlines, regulatory and compliance violations, frustrated users, operational drag and potential millions in lost value.

TransferAssist℠: A Unique Solution for AM&D Integrations

fme has helped several of our clients through these challenges, and realized the industry needed a proven, scalable, automation-powered solution that eliminates the friction and accelerates the acquisition, merger and divestiture process.

We also recognized that while M&A initiatives are generally independent projects, most firms will go through several AM&D cycles, often within a few years depending on economic and industry business conditions. Any solution would need to be standardized and repeatable, building a solid foundation and framework that would further accelerate each subsequent event.

With these common issues in mind, fme created TransferAssist℠, a comprehensive solution that simplifies the AM&D data consolidation/separation process from initial due diligence and system evaluation through final integration and go-live.

Learn More In Our Webinar Recording

On Thursday, September 18th fme presented Merger Ready RIM: Building Confidence in Every AM&D Transition with our associates at TOPRA, The Organization for Regulatory Professionals in Regulatory Affairs. In this session we shared details on how you can shift from project-based chaos to programmatic control using the proven, structured methodology of TransferAssist. We’d love to get your perspective and answer any questions you have about how to simplify AM&D data transitions.

Why View This Webinar?

In this session, you’ll learn:

    • The most frequent regulatory challenges during AM&D initiatives.
    • Proven short-term tactics to reduce risk and maintain compliance.
    • Long-term strategies to standardize, accelerate, and strengthen your regulatory data model.

You’ll also learn how TransferAssist helps Life Sciences companies:

    • Build a repeatable, scalable process for acquisitions and divestitures
    • Accelerate integrations with automation and AI
    • Maintain regulatory compliance and data quality throughout the process
    • Reduce IT burden while ensuring business continuity and user adoption

Webinar Details

Title: Merger Ready RIM: Building Confidence in Every AM&D Transition

Date: Recorded Thursday, September 18, 2025

 

Who Should View?

    • Senior Managers, Directors, and VPs responsible for IT, Regulatory Affairs, Quality, and Operations
    • M&A program leaders looking to reduce complexity and risk in their integration strategy
    • Business and technology leaders tasked with ensuring compliance and business continuity in high-stakes transitions

If your growth strategy depends on acquisitions or divestitures, you can’t afford to improvise. With TransferAssist, you’ll gain a future-proof framework to manage the data and content complexities of AM&D before, during, and after the deal.